Could a simple blood or urine test spot bladder cancer earlier?

NCT ID NCT07763197

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study is collecting blood, urine, and tumor tissue samples from about 400 adults with suspected high-risk non-muscle invasive bladder cancer. The goal is to find biological markers that could lead to new tests for detecting and monitoring this type of cancer. Participants will provide samples during standard care procedures, and researchers will analyze them to see if they can identify signs of cancer. This is a research study, not a treatment trial, so participants will not receive any experimental therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
No drug or treatment is being tested. This study collects blood, urine, and tumor tissue samples for research.
What this could lead to
If successful, this could help develop better blood or urine tests to detect and monitor bladder cancer, potentially improving early detection and follow-up care.
What could go wrong
This is an early research study focused on sample collection, not a treatment trial. It may not lead to a usable test, and any future test would need much more validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Natera, Inc.

    RECRUITING

    Austin, Texas, 78753, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.